Prescribing of continuous glucose monitoring sensors by all Sub-ICB Locations

Why it matters: Continuous glucose monitoring devices (CGM) can significantly reduce the need for people with diabetes to conduct finger-prick testing.

NICE guidance for Type 1 diabetes in adults, Type 2 diabetes in adults and Type 1 and Type 2 diabetes in children and young people were all updated in March 2022. The updates include recommendations that all patients with type 1 diabetes should be offered a choice of real-time continuous glucose monitoring (rtCGM) or intermittently scanned continuous glucose monitoring (isCGM) and that adults with type 2 diabetes on multiple daily insulin injections should be offered GM where they meet specific clinical criteria.

Description: Prescribing of continuous glucose monitoring sensors per 1000 patients


Tagged as: Standard, Diabetes (or browse all measures)

Sub-ICB Locations are ordered by mean percentile over the past six months. Each chart shows the results for the individual Sub-ICB Location, plus deciles across all Sub-ICB Locations in the NHS in England.

View measure for NHS England combined →

Fetching data...

Do you need help with your analysis? Don't forget to check the FAQ page, and get in touch if you have questions.